These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 16102451)

  • 1. Are neointimal smooth muscle cells in human cardiac allograft vasculopathy of donor origin?
    Beranek JT
    J Heart Lung Transplant; 2005 Aug; 24(8):1121-2. PubMed ID: 16102451
    [No Abstract]   [Full Text] [Related]  

  • 2. Neointimal smooth muscle cells in human cardiac allograft coronary artery vasculopathy are of donor origin.
    Atkinson C; Horsley J; Rhind-Tutt S; Charman S; Phillpotts CJ; Wallwork J; Goddard MJ
    J Heart Lung Transplant; 2004 Apr; 23(4):427-35. PubMed ID: 15063402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenetic mechanisms of cardiac allograft vasculopathy--impact of nitric oxide.
    Koglin J
    Z Kardiol; 2000; 89 Suppl 9():IX/24-7. PubMed ID: 11151787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Circulating recipient cells contribute to graft coronary arteriosclerosis].
    Sata M; Hirata Y; Nagai R
    J Cardiol; 2002 Jan; 39(1):48-9. PubMed ID: 11828797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allograft vasculopathy versus atherosclerosis.
    Rahmani M; Cruz RP; Granville DJ; McManus BM
    Circ Res; 2006 Oct; 99(8):801-15. PubMed ID: 17038650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transplant vascular disease: role of lipids and proteoglycans.
    Rahmani M; McDonald PC; Wong BW; McManus BM
    Can J Cardiol; 2004 Aug; 20 Suppl B():58B-65B. PubMed ID: 15309207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Undifferentiated vascular endothelial cells present in transplantation atherosclerosis display smooth muscle actin-positive cytoplasmic myofilaments.
    Beranek JT
    J Heart Lung Transplant; 1993; 12(5):886-7. PubMed ID: 8241238
    [No Abstract]   [Full Text] [Related]  

  • 8. Intimal fibrosis in human cardiac allograft vasculopathy.
    Huibers M; De Jonge N; Van Kuik J; Koning ES; Van Wichen D; Dullens H; Schipper M; De Weger R
    Transpl Immunol; 2011 Sep; 25(2-3):124-32. PubMed ID: 21782945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recipient origin of neointimal vascular smooth muscle cells in cardiac allografts with transplant arteriosclerosis.
    Hillebrands J; van den Hurk BM; Klatter FA; Popa ER; Nieuwenhuis P; Rozing J
    J Heart Lung Transplant; 2000 Dec; 19(12):1183-92. PubMed ID: 11124488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neointimal inflammation and adventitial angiogenesis correlate with severity of cardiac allograft vasculopathy in pediatric recipients.
    Seipelt IM; Pahl E; Seipelt RG; Mavroudis C; Backer CL; Stellmach V; Cornwell M; Crawford SE
    J Heart Lung Transplant; 2005 Aug; 24(8):1039-45. PubMed ID: 16102439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokine-mediated fibronectin production and transendothelial migration of lymphocytes in the mechanism of cardiac allograft vascular disease: efficacy of novel therapeutic approaches.
    Rabinovitch M; Molossi S; Clausell N
    J Heart Lung Transplant; 1995; 14(6 Pt 2):S116-23. PubMed ID: 8719473
    [No Abstract]   [Full Text] [Related]  

  • 12. Carotid intima media thickness and cardiac allograft vasculopathy after heart transplantation in childhood.
    Dalla Pozza R; Greil S; Januszewska K; Netz H; Kozlik-Feldmann R
    Transplantation; 2011 Mar; 91(6):e46-7. PubMed ID: 21383604
    [No Abstract]   [Full Text] [Related]  

  • 13. Angiogenesis occurs within the intimal proliferation that characterizes transplant coronary artery vasculopathy.
    Atkinson C; Southwood M; Pitman R; Phillpotts C; Wallwork J; Goddard M
    J Heart Lung Transplant; 2005 May; 24(5):551-8. PubMed ID: 15896752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low molecular weight fucan prevents transplant coronaropathy in rat cardiac allograft model.
    Alkhatib B; Freguin-Bouilland C; Lallemand F; Henry JP; Litzler PY; Marie JP; Richard V; Thuillez C; Plissonnier D
    Transpl Immunol; 2006 Jun; 16(1):14-9. PubMed ID: 16701171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angio-associated migratory cell protein and smooth muscle cell migration in development of restenosis and atherosclerosis.
    Holvoet P; Sinnaeve P
    J Am Coll Cardiol; 2008 Jul; 52(4):312-4. PubMed ID: 18634988
    [No Abstract]   [Full Text] [Related]  

  • 16. The chemokine and chemokine receptor profile of infiltrating cells in the wall of arteries with cardiac allograft vasculopathy is indicative of a memory T-helper 1 response.
    van Loosdregt J; van Oosterhout MF; Bruggink AH; van Wichen DF; van Kuik J; de Koning E; Baan CC; de Jonge N; Gmelig-Meyling FH; de Weger RA
    Circulation; 2006 Oct; 114(15):1599-607. PubMed ID: 17015796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Origin of the smooth muscle cells in intimal hyperplasia: do we come to the end of the tunnel?
    Beranek JT
    J Heart Lung Transplant; 1993; 12(1 Pt 1):152-4. PubMed ID: 8318075
    [No Abstract]   [Full Text] [Related]  

  • 18. Atherogenesis: current understanding of the causes of atheroma.
    Weissberg PL
    Indian Heart J; 2000; 52(4):467-72. PubMed ID: 11084797
    [No Abstract]   [Full Text] [Related]  

  • 19. [Mechanisms of transplant vasculopathy].
    Baron H; Plenz G; Deng MC
    Dtsch Med Wochenschr; 2004 Oct; 129(41):2193-7. PubMed ID: 15457400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic significance of intimal proliferation in cardiac allograft vasculopathy: a paradigm shift.
    Mehra MR; Ventura HO; Stapleton DD; Smart FW
    J Heart Lung Transplant; 1995; 14(6 Pt 2):S207-11. PubMed ID: 8719487
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.